
Associate Director, IO Forecasting
AstraZeneca
Summary
Ready to turn rigorous forecasting into decisions that change the trajectory of cancer care? As Associate Director, IO Forecasting, you will own the end-to-end forecasting agenda for a flagship Immuno-Oncology brand in the US, delivering the clarity our business needs to invest with confidence and reach more patients. Your work will set the pace for planning, launch readiness, and supply—translating complex signals into a single, credible view of the future.
Job description
You will be a thought partner to commercial leaders, building short- and long-term outlooks through patient-flow models and statistical trending, and crystallizing risks, opportunities, and scenarios. Working in close partnership with Insights & Analytics, Marketing, Sales, Market Access, Sales Operations, Global Analytics & Insights, Supply Planning, and Finance, you will align assumptions and narrative, then bring them to life for senior stakeholders. In a dynamic Oncology environment, you will also help advance our AI-enabled forecasting capabilities—accelerating insight generation, improving precision, and scaling best practices across the portfolio.
Accountabilities
- US IO Forecast Leadership: Lead US forecasting and business planning for new Immuno-Oncology products, consolidating the IO portfolio forecast to inform strategy, resource allocation, and performance management.
- Forecast Model Ownership: Build, maintain, and continuously refine product-specific short- and long-term models that are transparent, scenario-ready, and grounded in patient and market dynamics.
- Market Drivers and Scenario Planning: Identify and pressure test key volume and value drivers, quantify risks and opportunities, and translate uncertainty into actionable scenarios for decision-making.
- Cross-Functional Alignment: Partner with commercial leaders and forecast collaborators to align on assumptions and performance narrative, ensuring one authoritative forecast informs all planning cycles.
- Brand Performance Analytics: Deliver in-depth analyses for critical business deliverables, connecting the “why” behind performance to strategic choices and next best actions.
- AI-Enabled Forecasting: Incorporate AI analytical tools into forecasting workflows; support ongoing development of the AI forecasting platform to improve speed, accuracy, and automation.
- Competitive and Market Monitoring: Track the external environment, competitive moves, and market developments; quickly reflect changes in forecast assumptions and guidance.
- Evidence Integration: Consult on primary market research and leverage secondary analytics to strengthen assumptions and validate signals.
- Executive Storytelling: Create and deliver compelling presentations to senior leaders, highlighting critical insights, implications, and recommended actions.
- C-Level Narrative Partnership: Collaborate with senior US leaders to craft a clear, concise performance narrative for a C-level audience.
- People Leadership and Coaching: Guide Forecasting & Performance Senior Managers and Senior Analysts, raising the bar on rigor, clarity, and influence.
- Capability Building and Automation: Advance forecasting capabilities and drive process efficiencies, automation, and innovation that scale across brands.
Essential Skills/Experience
- Bachelor's degree, preferably in a quantitative field (e.g., Engineering, Data Science, Statistics, Math, Economics, Computer Science, Operations Research).
- Proven experience at a pharmaceutical/biotechnology manufacturer or in the biopharmaceutical industry (e.g., forecasting, data/analytics, management consulting, market research, investment banking).
- 4 years of experience in forecasting: building models, leading input evaluation, communicating outputs, and guiding business decisions; 2 years specifically in a biopharmaceutical role.
- Deep expertise in building pharmaceutical forecast models and leading/optimizing the full forecasting process.
- Experienced in evaluating analytics from pharmaceutical data sources (APLD, IQVIA, claims) and epidemiological data (Kantar, DRG).
- Experience with primary market research, advanced analytics, and competitive intelligence.
Desirable Skills/Experience
- Advanced Quantitative Degree or Advanced Marketing Degree (e.g., MBA).
- Experience working in Oncology.
Requirements
- Bachelor's degree, preferably in a quantitative field (e.g., Engineering, Data Science, Statistics, Math, Economics, Computer Science, Operations Research)
- Proven experience at a pharmaceutical/biotechnology manufacturer or in the biopharmaceutical industry
- 4 years of experience in forecasting: building models, leading input evaluation, communicating outputs, and guiding business decisions
- 2 years specifically in a biopharmaceutical role
- Deep expertise in building pharmaceutical forecast models and leading/optimizing the full forecasting process
- Experienced in evaluating analytics from pharmaceutical data sources (APLD, IQVIA, claims) and epidemiological data (Kantar, DRG)
- Experience with primary market research, advanced analytics, and competitive intelligence
Benefits
- Retirement Programs
- Paid Time Off
- Health Insurance
- Dental Coverage
- Vision Coverage
- Short-Term Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.